by Matt Batcheldor
Jonathan Menachem, MD, a transplant cardiologist and director of Advanced Congenital Cardiac Therapies (ACCT) at Vanderbilt Health, has been named to the Medical Advisory Board of the Adult Congenital Heart Association.
“We are incredibly excited for the addition of Dr. Jonathan Menachem to the Adult Congenital Heart Association Medical Advisory Board and look forward to the expert input and oversight he will provide,” said ACHA president & CEO Mark Roeder.
“The remarkable contributions he has brought to the field of adult congenital disease are a tremendous asset to our organization.”
Menachem joined Vanderbilt University Medical Center in 2017 after completing a cardiology and heart transplant fellowship at the University of Pennsylvania, which included one year dedicated to treating adults with congenital heart disease.
Menachem completed his residency in internal medicine at Duke University. He received his MD from Tulane School of Medicine and his bachelor’s degree in Economics from Duke.
“I am incredibly excited to be given this opportunity,” Menachem said. “ACHA has been led by the leaders in the field of congenital heart disease, and I am honored to learn from and work alongside them to improve the care we can provide to this deserving group of patients.”
The mission of ACHA is to improve and extend the lives of the millions born with heart defects through education, advocacy and research.
